Semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, is a medication used for weight loss, type 2 diabetes management, and cardiovascular risk reduction. It operates by increasing insulin release, decreasing glucagon levels, delaying gastric emptying, and curbing appetite. The drug is available under three brand names: Ozempic, Wegovy, and Rybelsus, each with specific uses and forms.
Ozempic is injected weekly and is used to control blood sugar levels in type 2 diabetic patients, alongside diet and exercise. It also helps reduce the risk of cardiovascular events in diabetic patients with pre-existing cardiovascular disease.
Wegovy is another weekly injection, approved by the FDA specifically for weight loss. It targets patients with a BMI of 30kg/m2 or greater, or a BMI of 27kg/m2 or greater with at least one weight-related condition. It is used in conjunction with diet and exercise.
Rybelsus is a daily tablet taken 30 minutes before eating, drinking, or taking other medications. It is used to manage blood sugar levels in type 2 diabetic patients and should be swallowed whole without being split, crushed, or chewed.
The dosage and administration vary by brand and patient needs. Ozempic and Wegovy are administered as subcutaneous injections, while Rybelsus is an oral tablet.
Common side effects include low blood sugar, upset stomach, heartburn, burping, gas, bloating, nausea, vomiting, stomach pain, loss of appetite, diarrhea, constipation, and symptoms of stomach flu. Serious side effects, such as allergic reactions, vision changes, mood changes, thyroid tumor signs, pancreatitis, gallbladder problems, low blood sugar, kidney problems, and stomach flu symptoms, require immediate medical attention.
Semaglutide is not for use in people with type 1 diabetes or those with certain medical conditions, such as multiple endocrine neoplasia type 2 or a history of medullary thyroid cancer. It is also not recommended for use during pregnancy or breastfeeding without medical advice.
Each brand has specific storage requirements, with Ozempic and Wegovy needing refrigeration before first use and Rybelsus stored at room temperature. The cost of semaglutide varies and depends on insurance coverage and pharmacy choice.
Semaglutide is a versatile medication for type 2 diabetes and weight loss, with specific brands tailored to different needs. It is essential to follow the prescribed dosage and administration guidelines and to consult with a healthcare provider for personalized advice and to report any adverse effects.